1.The Impact of a Spouse's Depression on Family Functioning and Communication.
Seung Hyun YOO ; Hyuk Ju KWON ; Sun Hee KIM ; Jung Ah LEE ; Sung SUNWOO ; Young Sik KIM ; Byung Su KIM ; Han Jin OH ; Chul Min KIM ; Hee Jeong CHOI ; Hee Jin HWANG ; Sun Wha OK
Korean Journal of Health Promotion 2016;16(1):11-19
BACKGROUND: Depression is known to affect family function and communication. However, the distress experienced by those who have spouse with depression has not been properly assessed to date. This study attempted to examine the effect of depression on family function and communication as reported by the spouses of the depressed patients. METHODS: The participants of this study were 445 couples who visited 28 family doctors from April 2009 to June 2011. The Family Adaptability and Cohesion Evaluation Scale III (FACES-III) was used to evaluate the family function, and the family communication scale in FACES-IV was used to evaluate communication among family members. A score of more than 21 points on the CES-D scale was used to indicate depression. The relationships between family type, family communication, and the depression of one's spouse were analyzed using the chi-square test and logistic regression. RESULTS: The odds ratios, indicating how the family is heading towards an extreme level, were statistically significant in all male and female respondents (male: odds ratio [OR] 3.08, 95% confidence interval [CI] 1.73-5.48; female: OR 2.09, 95% CI 1.02-4.27). On the other hand, only female respondents with depressed spouses reported their family communication not to be good (male: OR 1.65, 95% CI 0.88-3.07; female: OR 2.48, 95% CI, 1.25-4.93). CONCLUSIONS: This study revealed people perceive their family function and communication not good when they have spouses with depression. There was no gender difference in the evaluation of their family function, but the perception on their family communication were different by gender.
Surveys and Questionnaires
;
Depression*
;
Family Characteristics
;
Female
;
Hand
;
Head
;
Humans
;
Logistic Models
;
Male
;
Odds Ratio
;
Spouses
2.A Case of Methanol Poisoning Treated with Continuous Renal Replacement Therapy: The Serial Measurements of Serum Methanol Concentrations in Methanol Poisoning.
Hyun Ju YANG ; Soo Wan CHAE ; Soon Ok NOH ; Yun Jo CHUNG ; Sung Sik OH ; Mi Rim CHOI ; Jong Wha LEE ; Myung Woo CHOI ; Hyun Ju YOON ; In O SUN ; Kwang Young LEE
Journal of the Korean Society of Emergency Medicine 2016;27(5):488-491
Methanol poisoning is a medical emergency that requires rapid elimination of the toxin and its metabolites for recovery. The danger of methanol results from the accumulation of its toxic metabolite formic acid. This accumulation may result in the development of metabolic acidosis, visual impairment, and damage to the basal ganglia. Extracorporeal treatment is recommended in severe cases of methanol poisoning with coma, seizure, new vision deficits, metabolic acidosis, high serum anion gap, elevated methanol concentrations or impaired kidney function. Although the serum methanol concentration is helpful in determining the use of extracorporeal treatment, methanol assays are not standard laboratory tests in Korea. Herein, we report a case of methanol poisoning in which the patient's clinical improvement was confirmed using serum and urine methanol levels.
Acid-Base Equilibrium
;
Acidosis
;
Basal Ganglia
;
Coma
;
Emergencies
;
Extracorporeal Circulation
;
Kidney
;
Korea
;
Methanol*
;
Osmolar Concentration
;
Poisoning*
;
Renal Replacement Therapy*
;
Seizures
;
Vision Disorders
3.Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study.
Gi Hyun KIM ; Jung Wha CHUNG ; Jong Ho LEE ; Kyeong Sam OK ; Eun Sun JANG ; Jaihwan KIM ; Cheol Min SHIN ; Young Soo PARK ; Jin Hyeok HWANG ; Sook Hyang JEONG ; Nayoung KIM ; Dong Ho LEE ; Jin Wook KIM
Clinical and Molecular Hepatology 2015;21(4):379-386
BACKGROUND/AIMS: Vitamin E improves the biochemical profiles and liver histology in nonalcoholic steatohepatitis, but the role of vitamin E is not clearly defined in the management of nonalcoholic fatty liver disease (NAFLD) which includes both simple steatosis and steatohepatitis. Co-morbid metabolic syndrome increases the probability of steatohepatitis in NAFLD. In this study, we aimed to determine the short-term effects of vitamin E and off-treatment durability of response in a propensity-score matched cohort of NAFLD patients with metabolic syndrome. METHODS: A retrospective cohort was constructed by retrieving 526 consecutive NAFLD patients from the electronic medical record data warehouse of a tertiary referral hospital in South Korea. Among them, 335 patients (63.7%) had metabolic syndrome and were eligible for vitamin E therapy. In order to assess the effect of vitamin E, propensity score matching was used by matching covariates between control patients (n=250) and patients who received vitamin E (n=85). RESULTS: The PS-matched vitamin E group (n=58) and control group (n=58) exhibited similar baseline metabolic profiles. After 6 months of vitamin E therapy, the mean ALT levels decreased significantly compared to PS-matched control (P<0.01). The changes in metabolic profiles (body weight, lipid and glucose levels) did not differ between control and vitamin E groups during the study period. CONCLUSIONS: Short-term vitamin E treatment significantly reduces ALT levels in NAFLD patients with metabolic syndrome, but metabolic profiles are not affected by vitamin E.
Adult
;
Aged
;
Alanine Transaminase/blood
;
Aspartate Aminotransferases/blood
;
Body Weight
;
Cohort Studies
;
Female
;
Humans
;
Lipoproteins, HDL/blood
;
Lipoproteins, LDL/blood
;
Liver/pathology
;
Male
;
Metabolic Syndrome X/*complications/diagnosis/drug therapy
;
Middle Aged
;
Non-alcoholic Fatty Liver Disease/*complications/diagnosis/*drug therapy
;
Propensity Score
;
Republic of Korea
;
Retrospective Studies
;
Vitamin E/*therapeutic use
4.The Relationship between a Spouse's Alcohol Use Disorder and Family Communication.
Hyuk Ju KWON ; Tae Kwan AHN ; Jung Ah LEE ; Sung SUNWOO ; Young Sik KIM ; Byung Soo KIM ; Tae Hee JEON ; Byung Yeon YU ; Byung Wook YOO ; Kyung Chae PARK ; Sun Wha OK
Korean Journal of Family Medicine 2015;36(2):92-102
BACKGROUND: Alcohol use disorder (AUD) affects not only an individual's health but also their family. This study was conducted to examine effects of a spouse's AUD on family functioning and family communication. METHODS: We conducted a cross-sectional study using data from 890 participants (445 couples) in a Korean family cohort in primary care. Participants with Alcohol Use Disorders Identification Test in Korea scores of 8 or greater were classified into an AUD group. Family functioning was classified into three groups (balanced, midrange, and extreme) using the Family Adaptability and Cohesion Scale (FACES)-III questionnaire, and then reclassified into two groups (appropriate and extreme groups) for binominal analyses. Family communication was classified into three groups (high, moderate, and low) using the Family Communication Scale, FACES-IV, and also reclassified into two groups (good and poor). RESULTS: There was no significant difference in adaptability and cohesion between both male and female participants with a spouse with AUD and participants with a spouse without AUD. Using multivariate logistic regression to adjust for potential confounders, there was no significant difference in family type and communication between the two groups in males. However, there was a significant decrease in family communication (odds ratio, 2.14; 95% confidence interval, 1.29 to 3.58) in females with a spouse with AUD compared to females with a spouse without AUD, even after adjusting for the participant's own AUD. CONCLUSION: In females, family communication is significantly worse when spouses have AUD. This suggests that a husband's alcohol consumption has negative effects on his wife's family communication.
Alcohol Drinking
;
Cohort Studies
;
Cross-Sectional Studies
;
Female
;
Humans
;
Korea
;
Logistic Models
;
Male
;
Primary Health Care
;
Surveys and Questionnaires
;
Spouses
5.Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
Jung Wha CHUNG ; Gi Hyun KIM ; Jong Ho LEE ; Kyeong Sam OK ; Eun Sun JANG ; Sook Hyang JEONG ; Jin Wook KIM
Clinical and Molecular Hepatology 2014;20(4):384-391
BACKGROUND/AIMS: Portal-vein thrombosis (PVT) develops in 10-25% of cirrhotic patients and may aggravate portal hypertension. There are few data regarding the effects of anticoagulation on nonmalignant PVT in liver cirrhosis. The aim of this study was to elucidate the safety, efficacy, and predictors of response to anticoagulation therapy in cirrhotic patients. METHODS: Patients with liver cirrhosis and nonmalignant PVT were identified by a hospital electronic medical record system (called BESTCARE). Patients with malignant PVT, Budd-Chiari syndrome, underlying primary hematologic disorders, or preexisting extrahepatic thrombosis were excluded from the analysis. Patients were divided into two groups (treatment and nontreatment), and propensity score matching analysis was performed to identify control patients. The sizes of the thrombus and spleen were evaluated using multidetector computed tomography. RESULTS: Twenty-eight patients were enrolled in this study between 2003 and 2014: 14 patients who received warfarin for nonmalignant PVT and 14 patients who received no anticoagulation. After 112 days of treatment, 11 patients exhibited significantly higher response rates (complete in 6 and partial in 5) compared to the control patients, with decreases in thrombus size of >30%. Compared to nonresponders, the 11 responders were older, and had a thinner spleen and fewer episodes of previous endoscopic variceal ligations, whereas pretreatment liver function and changes in prothrombin time after anticoagulation did not differ significantly between the two groups. Two patients died after warfarin therapy, but the causes of death were not related to anticoagulation. CONCLUSIONS: Warfarin can be safely administered to cirrhotic patients with nonmalignant PVT. The presence of preexisting portal hypertension is a predictor of nonresponse to anticoagulation.
Aged
;
Anticoagulants/*therapeutic use
;
Female
;
Humans
;
Liver Cirrhosis/complications/*diagnosis
;
Male
;
Middle Aged
;
Portal Vein
;
Propensity Score
;
Severity of Illness Index
;
Tomography, X-Ray Computed
;
Venous Thrombosis/complications/*drug therapy/pathology
;
Warfarin/therapeutic use
6.Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study.
Ae Ra HAN ; Hye Ok KIM ; Sun Wha CHA ; Chan Woo PARK ; Jin Yeong KIM ; Kwang Moon YANG ; In Ok SONG ; Mi Kyoung KOONG ; Inn Soo KANG
Clinical and Experimental Reproductive Medicine 2011;38(2):103-108
OBJECTIVE: To investigate adverse pregnancy outcomes in non-obese women with polycystic ovary syndrome (PCOS) compared with obese-PCOS and control groups. METHODS: Women with PCOS who underwent assisted reproductive technology (ART) from August, 2003 to December, 2007, were considered. A total of 336 women with PCOS were included in the study group and 1,003 infertile women who had tubal factor as an indication for ART were collected as controls. They were divided into four groups: a non-obese PCOS group, obese-PCOS group, non-obese tubal factor group, and obese tubal factor group, with obesity defined by a body mass index over 25 kg/m2, and reviewed focusing on the basal characteristics, ART outcomes, and adverse pregnancy outcomes. RESULTS: There was no difference among the groups' the clinical pregnancy rate or live birth rate. Regarding adverse pregnancy outcomes, the miscarriage rate, multiple pregnancy rate, and prevalence of preterm delivery and pregnancy induced hypertension were not different among the four groups. The incidence of small for gestational age infant was higher in the PCOS groups than the tubal factor groups (p<0.02). On the other hand, the morbidity of gestational diabetes mellitus (GDM) was not high in the non-obese PCOS group but was in the obese groups. And in the obese PCOS group, the newborns were heavier than in the other groups (p<0.02). CONCLUSION: Non-obese PCOS presents many differences compared with obese PCOS, not only in the IVF-parameters but also in the morbidity of adverse pregnancy outcomes, especially in GDM and fetal macrosomia.
Abortion, Spontaneous
;
Body Mass Index
;
Case-Control Studies
;
Diabetes, Gestational
;
Female
;
Fetal Macrosomia
;
Gestational Age
;
Hand
;
Humans
;
Hypertension, Pregnancy-Induced
;
Incidence
;
Infant
;
Infant, Newborn
;
Live Birth
;
Obesity
;
Ovary
;
Polycystic Ovary Syndrome
;
Pregnancy
;
Pregnancy Outcome
;
Pregnancy Rate
;
Pregnancy, Multiple
;
Prevalence
;
Reproductive Techniques, Assisted
7.Age specific serum anti-Mullerian hormone levels in 1,298 Korean women with regular menstruation.
Ji Hee YOO ; Hye Ok KIM ; Sun Wha CHA ; Chan Woo PARK ; Kwang Moon YANG ; In Ok SONG ; Mi Kyoung KOONG ; Inn Soo KANG
Clinical and Experimental Reproductive Medicine 2011;38(2):93-97
OBJECTIVE: To determine the age specific serum anti-Mullerian hormone (AMH) reference values in Korean women with regular menstruation. METHODS: Between May, 2010 and January, 2011, the serum AMH levels were evaluated in a total of 1,298 women who have regular menstrual cycles aged between 20 and 50 years. Women were classified into 6 categories by age: 20-31 years, 32-34 years, 35-37 years, 38-40 years, 41-43 years, above 43 years. Measurement of serum AMH was measured by commercial enzyme-linked immunoassay. RESULTS: The serum AMH levels correlated negatively with age. The median AMH level of each age group was 4.20 ng/mL, 3.70 ng/mL, 2.60 ng/mL, 1.50 ng/mL, 1.30 ng/mL, and 0.60 ng/mL, respectively. The AMH values in the lower 5th percentile of each age group were 1.19 ng/mL, 0.60 ng/mL, 0.42 ng/mL, 0.27 ng/mL, 0.14 ng/mL, and 0.10 ng/mL, respectively. CONCLUSION: This study determined reference values of serum AMH in Korean women with regular menstruation. These values can be applied to clinical evaluation and treatment of infertile women.
Aged
;
Anti-Mullerian Hormone
;
Female
;
Humans
;
Menstrual Cycle
;
Menstruation
;
Reference Values
8.Cerebral Adrenomyeloneuropathy with Trp77-Leu82del Mutation in ABCD1 Gene.
Kyu Sun LEE ; Eun Kyung PARK ; Young Se HYUN ; Hae Jin LEE ; Ki Wha CHUNG ; Hea Soo KOO ; Kyoung Gyu CHOI ; Kee Duk PARK ; Byung Ok CHOI
Journal of the Korean Neurological Association 2011;29(4):356-360
Cerebral adrenomyeloneuropathy is a subtype of X-linked adrenoleukodystrophy with a mutation of ABCD1; however, there have been no reported cases of cerebral adrenomyeloneuropathy with myelopathy. Here we report a 20-year-old male cerebral adrenomyeloneuropathy patient with myelopathy harboring a deletion mutation of c.225-242 (Trp77-Leu82del) from exon 1 of ABCD1. His spinal cord MRI revealed high signal intensities in the cervical spinal cord. Electrophysiological and histopathologic studies revealed mixed axonal and demyelinating neuropathy.
Adrenoleukodystrophy
;
Axons
;
Exons
;
Humans
;
Male
;
Sequence Deletion
;
Spinal Cord
;
Spinal Cord Diseases
;
Young Adult
9.Vancomycin-Associated Spontaneous Cutaneous Adverse Drug Reactions.
So Yeon AN ; Eui Kyung HWANG ; Joo Hee KIM ; Jeong Eun KIM ; Hyun Jung JIN ; Sun Min JIN ; Jin Ok KYUN ; Young Hee LEE ; Hae Sim PARK ; Young Wha CHOI ; Seung Kwan LIM ; Young Min YE
Allergy, Asthma & Immunology Research 2011;3(3):194-198
PURPOSE: With the increase in vancomycin use, adverse drug reactions (ADRs) associated with vancomycin have been reported increasingly more often. However, the characteristics of cutaneous ADRs with and without systemic reactions (SRs) have not been described. This study investigated the characteristics of spontaneously reported and assessed ADRs associated with vancomycin by a pharmacovigilance center. METHODS: ADRs (n=121) associated with vancomycin in 96 patients were collected from 2008 to 2009. Records from physician- and nurse-reported suspected cases of vancomycin ADRs, ADR type, latent period, and laboratory results were compared between cutaneous ADRs with and without SRs. RESULTS: The main vancomycin-related ADRs were skin rashes (47.9%), hematologic abnormalities (17.36%), fever (12.4%), and elevated serum creatinine (12.4%). Significant differences were observed in latent period (days) and the mean change in eosinophils (%) between cutaneous (9.21+/-9.71 and 1.4+/-3.4, respectively) and other ADRs (14.03+/-11.71 and -0.5+/-3.5, respectively). Twelve cases of cutaneous ADRs with SRs had been initially reported as cutaneous ADRs only. Mean changes in the eosinophil count were significantly higher for cutaneous ADRs with SRs compared to those without SRs. CONCLUSIONS: Skin rashes accompanied by peripheral eosinophilia, representing suspected immune-mediated delayed hypersensitivity reactions, are a common vancomycin ADR. For the early and exact detection of ADRs associated with vancomycin administration, close monitoring of laboratory tests, including complete blood counts with differential analysis, is recommended.
Blood Cell Count
;
Creatinine
;
Drug Toxicity
;
Eosinophilia
;
Eosinophils
;
Exanthema
;
Fever
;
Humans
;
Hypersensitivity, Delayed
;
Pharmacovigilance
;
Vancomycin
10.Kidney Length in Normal Korean Children.
In One KIM ; Jung Eun CHEON ; Young Seok LEE ; Sun Wha LEE ; Ok Hwa KIM ; Ji Hye KIM ; Hong Dae KIM ; Jung Suk SIM
Journal of the Korean Society of Medical Ultrasound 2010;29(3):181-188
PURPOSE: Renal length offers important information to detect or follow-up various renal diseases. The purpose of this study was to determine the kidney length of normal Korean children in relation to age, height, weight, body surface area (BSA), and body mass index (BMI). MATERIALS AND METHODS: Children between 1 month and 15 years of age without urological abnormality were recruited. Children below 3rd percentile and over 97th percentile for height or weight were excluded. Both renal lengths were measured in the prone position three times and then averaged by experienced radiologists. The mean length and standard deviation for each age group was obtained, and regression equation was calculated between renal length and age, weight, height, BSA, and BMI, respectively. RESULTS: Renal length was measured in 550 children. Renal length grows rapidly until 24 month, while the growth rate is reduced thereafter. The regression equation for age is: renal length (mm) = 45.953 + 1.064 x age (month, < or = 24 months) (R2 = 0.720) or 62.173 + 0.203 x age (months, > 24 months) (R2 = 0.711). The regression equation for height is: renal length (mm) = 24.494 + 0.457 x height (cm) (R2 = 0.894). The regression equation for weight is: renal length (mm) = 38.342 + 2.117 x weight (kg, < or =18 kg) (R2 = 0.852) or 64.498 + 0.646 x weight (kg, > 18 kg) (R2 = 0.651). The regression equation for BSA is: renal length (mm) = 31.622 + 61.363 xBSA (m2, < or = 0.7) (R2 = 0.857) or 52.717 + 29.959 x BSA (m2, > 0.7) (R2 = 0.715). The regression equation for BMI is: renal length (mm) = 44.474 + 1.163 x BMI (R2 = 0.079). CONCLUSION: This study provides data on the normal renal length and its association with age, weight, height, BSA and BMI. The results of this study will guide the detection and follow-up of renal diseases in Korean children.
Body Mass Index
;
Body Weight
;
Child
;
Follow-Up Studies
;
Humans
;
Kidney
;
Prone Position

Result Analysis
Print
Save
E-mail